Published in

Elsevier, Clinical Microbiology and Infection, 5(11), p. 415-418, 2005

DOI: 10.1111/j.1469-0691.2005.01102.x

Links

Tools

Export citation

Search in Google Scholar

Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia

Journal article published in 2005 by C.-I. Kang, S.-H. Kim, W. B. Park ORCID, K.-D. Lee, H.-B. Kim ORCID, E.-C. Kim, M.-D. Oh, K.-W. Choe
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Cases of community-acquired Pseudomonas aeruginosa bacteraemia (n = 39) that occurred at a tertiary-care hospital during a 5-year period were analysed retrospectively. The commonest underlying diseases were solid tumour (41%) and haematological malignancy (18%). Most (44%) of the patients were neutropenic, and 39% had septic shock at initial presentation. The 30-day attributable mortality rate was 39%. Two previously healthy patients were identified with fatal P. aeruginosa pneumonia with bacteraemia. P. aeruginosa bacteraemia is a fatal infection that should be considered in the differential diagnosis of patients presenting from the community with rapidly progressive sepsis.